Editorial: Asian health sector growth in the next decade—Optimism despite challenges ahead

Jakovljević, Mihajlo; Wang, Liang; Adhikari, Chiranjivi

doi:10.3389/fpubh.2023.1150917

Cited by 4 publications

(3 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Social health insurance is not sufficient, and therefore the payment system must be improved to coincide with the increase in medical costs. 35 Increasing transparency of medical progress may also help control the overuse of medical funds. 36 The Chinese government has launched CHS-DRG and diagnosis-intervention packet pilot programs to solve this problem, and more incentives must be created to ensure that doctors, patients, and the Healthcare Security Administration of Chengdu are actively involved in controlling healthcare costs.…”

Section: Discussionmentioning

confidence: 99%

Big Data-Enabled Analysis of Factors Affecting Medical Expenditure in the Cerebral Infarction of a Developing City in Western China

Zeng,

Zhang,

Guo

et al. 2023

RMHP

View full text Add to dashboard Cite

Purpose Cerebral infarction (CI) has been one of the leading causes of death in China since 2017, and controlling the medical expenses of this disease is an urgent issue for the Chinese government. This study aims to explore the important factors that affect the hospitalization expenses of CI patients and to provide a scientific basis for establishing a reasonable reimbursement mechanism and hospitalization expense standard for CI patients. Methods Data from 109,314 inpatients from the Healthcare Security Administration of Chengdu in western China from January 2016 to December 2018 were utilized. Descriptive statistical analysis was used for variable characteristic analysis. The Mann–Whitney test and Kruskal–Wallis test were used for single-factor analysis, and multiple linear stepwise regression was used for single-factor analysis and multiple-factor analysis. Results This study found that the average direct economic burden of CI in Chengdu was approximately 10,569 Chinese yuan (CNY), about 1450 US dollars, the average length of stay (LOS) was 14.47 days, the indirect economic burden was approximately 2817 CNY, and the total economic burden was 13,386 CNY for a CI inpatient. Gender, insurance type, grade of medical institution, the level of payment type, age, LOS, and complications and comorbidities (CCs) are the most important factors affecting CI medical costs. Conclusion Citizens should improve their lifestyle habits to reduce disease risk to avoid the associated medical and economic burdens. Hospitals should improve their medical technology to decrease the LOS and reduce direct medical costs. The government should actively promote the hierarchical diagnosis and treatment policy to reduce the waste of medical resources caused by low-acuity patients going to high-level hospitals for treatment. The National Healthcare Security Administration should optimize the medical insurance payment method and establish a corresponding mechanism to reduce the occurrence of excessive medical treatments such as overuse.

show abstract

Section: Discussionmentioning

confidence: 99%

Big Data-Enabled Analysis of Factors Affecting Medical Expenditure in the Cerebral Infarction of a Developing City in Western China

Zeng,

Zhang,

Guo

et al. 2023

RMHP

View full text Add to dashboard Cite

show abstract

“…The Chinese healthcare security system and medicine have developed rapidly over the last two decades ( Jakovljevic et al, 2023 ; Jakovljevic et al, 2021 ), and healthcare-related sectors have been subjected to several reforms ( Micah et al, 2021 ). Moreover, China ranks first among the BRICS countries in growth rate ( Jakovljevic, 2014 ; Timofeyev et al, 2023 ), and China's healthcare expenditure has increased at a faster pace in tandem with the nation's economic development ( Jakovljevic, Wang, & Adhikari, 2023 ; Sahoo et al, 2023 ). The continuous improvement of the healthcare system has reduced the health-related disparities in China's population ( Jakovljevic et al, 2016 , Jakovljevic et al, 2022 ).…”

Section: Introductionmentioning

confidence: 99%

Party membership and self-assessed health: Evidence from the Communist Party of China

Zhang,

Gao

2024

SSM - Population Health

View full text Add to dashboard Cite

“…This Research Topic was created to tackle the core challenges of medicines provision and medical care financing across the Globe ( 15 ). Its target is to reveal hidden underlying causes of uneven drug access and the growing proportion of out-of-pocket health spending in many regions ( 16 ). In its basis, the Topic belongs to the interdisciplinary sciences of pharmacoeconomics and health economics.…”

mentioning

confidence: 99%

Editorial: Challenges of pharmacoeconomics in global health arena—Contemporary momentum in the early 2020s

Jakovljević

Verhaeghe

Souliotis

et al. 2023

Front. Public Health

Self Cite

View full text Add to dashboard Cite

Editorial on the Research Topic Challenges of pharmacoeconomics in global health arena-Contemporary momentum in the early sPharmaceutical markets worldwide expose substantial stratification in their Composite Annual Growth Rates (CAGR) (1). This is best visible when observing landscape diversity among the traditionally wealthier OECD countries and leading Emerging Markets such as the BRICS (Brazil, Russia, India, China, South Africa) and EM7 (BRIC+ Mexico, Indonesia, Turkey) (Jakoljevic et al., 2020). An abundance of seminal evidence documents that accurate GDP growth rates and dynamics of global demand for medical services and pharmaceuticals will remain primarily driven by the Emerging Markets as we approach the 2030s. Long-term investment strategies of the leading brand-name Big-Pharma multinationals are targeted precisely toward these same rapidly developing world regions (2). The epicenter of global economic growth appears to remain in the Western Pacific Asia region up to the middle of the century. The pace of globalization has significantly accelerated since the end of the Cold War Era in 1991 (3). These changes profoundly affected healthcare systems worldwide. Health policymakers increasingly started facing new harsh challenges in their uneasy task to provide universal health coverage and decent equity of access to health care services (4). The most prominent demand-side issues are extended longevity, population aging, the rise of non-communicable diseases and growing patient expectations. Supply-side causes are:• gains in societal welfare and living standards, • technological innovation in medicine, • rapid urbanization in developing world regions.

show abstract

Editorial: Asian health sector growth in the next decade—Optimism despite challenges ahead

Cited by 4 publications

References 10 publications

Big Data-Enabled Analysis of Factors Affecting Medical Expenditure in the Cerebral Infarction of a Developing City in Western China

Big Data-Enabled Analysis of Factors Affecting Medical Expenditure in the Cerebral Infarction of a Developing City in Western China

Party membership and self-assessed health: Evidence from the Communist Party of China

Editorial: Challenges of pharmacoeconomics in global health arena—Contemporary momentum in the early 2020s

Contact Info

Product

Resources

About